• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Clinuvel Pharmaceuticals Ltd

+ Add to Watchlist

CLVLY:US

3.9500 USD 0.2200 5.28%

As of 15:31:43 ET on 11/25/2014.

Snapshot for Clinuvel Pharmaceuticals Ltd (CLVLY)

Open: 4.0000 Day's Range: 3.9000 - 4.0300 Volume: 35,841
Previous Close: 4.1700 52wk Range: 0.9000 - 5.0000 1-Yr Rtn: +192.59%

Stock Chart for CLVLY

No chart data available.
  • CLVLY:US 3.9500
  • 1D
  • 1M
  • 1Y
4.1700
Interactive CLVLY Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CLVLY

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 167.74
Shares Outstanding (M) 42.47
30 Day Average Volume 67,747
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend (USD) 0.0031
Dividend Ex-Date 11/03/2006
5 Year Dividend Growth -
Next Earnings Announcement 02/26/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CLVLY

  • Revenue
  • Net Income (M/AUD)
  • Profit Margin (%)

Company Profile & Key Executives for CLVLY

Clinuvel Pharmaceuticals Limited is an Australian biopharmaceutical company. The company focused on developing dermatology pharmaceutical products for a range of UV-related skin disorders. Clinuvel's work aims at preventing the symptoms of diseases related to harmful UV radiation.

Philippe J WolgenManaging Director/CEODarren M KeamyCFO/Secretary
Dennis J WrightActing Chief Scientific OfcrDavina GunnMgr:Investor Rels & Marketing
More Company Profile & Key Executives for CLVLY

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil